Sign in to check this stock against your screeners
Sign InUS92532F1003Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis....
$56.95
1D:
-0.7%
1Y:
13.8%
US1101221083Mkt Cap
$116.28B
P/E Ratio TTM
16.4
Revenue TTM
$48.19B
Beta
0.26
Earnings TTM
$7.05B
Dividend Yield TTM
4.29%
$295.25
1D:
1.5%
1Y:
-22.6%
US8636671013Mkt Cap
$113.08B
P/E Ratio TTM
33.8
Revenue TTM
$25.12B
Beta
0.81
Earnings TTM
$3.25B
Dividend Yield TTM
1.17%
This company does not pay dividends